The observation that PLA2G7, the encoding gene for Lp-PLA2, is also overexpressed in the pathogenesis of cardiovascular diseases and ischemic stroke suggests that dissection of the upstream regulatory mechanism of PLA2G7 may benefit the development of therapeutic strategies to decrease Lp-PLA2 activity and mass. This evidence concerns the gene PLA2G7 and ischemic stroke.